Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
2201
Chatham Lodging
CLDT
$348M
| $12.6M | ﹤0.01% |
1,174,908
+57,772
| +5% | +$619K |
|
2202
Seaboard Corp
SEB
$3.78B
| $12.6M | ﹤0.01% |
3,519
+24
| +0.7% | +$85.7K |
|
2203
Liquidia Corp
LQDA
$2.24B
| $12.5M | ﹤0.01% |
1,042,909
+50,810
| +5% | +$611K |
|
2204
A-Mark Precious Metals
AMRK
$664M
| $12.5M | ﹤0.01% |
414,274
+19,781
| +5% | +$598K |
|
2205
SmartRent
SMRT
$273M
| $12.5M | ﹤0.01% |
3,925,259
+216,422
| +6% | +$690K |
|
2206
Washington Trust Bancorp
WASH
$573M
| $12.5M | ﹤0.01% |
386,056
+16,595
| +4% | +$537K |
|
2207
Manitowoc
MTW
$362M
| $12.5M | ﹤0.01% |
748,319
+32,630
| +5% | +$545K |
|
2208
Logitech
LOGI
$16B
| $12.5M | ﹤0.01% |
131,189
-718
| -0.5% | -$68.3K |
|
2209
Shoe Carnival
SCVL
$636M
| $12.5M | ﹤0.01% |
412,209
+27,988
| +7% | +$846K |
|
2210
Hudson Technologies
HDSN
$444M
| $12.4M | ﹤0.01% |
920,757
+48,143
| +6% | +$650K |
|
2211
MeridianLink
MLNK
$1.47B
| $12.4M | ﹤0.01% |
501,203
+28,988
| +6% | +$718K |
|
|
ATRI
2212
DELISTED
Atrion Corp
ATRI
| $12.4M | ﹤0.01% |
32,760
+1,699
| +5% | +$644K |
|
2213
Dyne Therapeutics
DYN
$1.87B
| $12.4M | ﹤0.01% |
932,838
+75,128
| +9% | +$999K |
|
|
MRNS
2214
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.4M | ﹤0.01% |
1,139,494
+94,546
| +9% | +$1.03M |
|
2215
Adaptive Biotechnologies
ADPT
$1.92B
| $12.4M | ﹤0.01% |
2,523,642
+107,763
| +4% | +$528K |
|
2216
Adtran
ADTN
$809M
| $12.4M | ﹤0.01% |
1,683,767
+58,129
| +4% | +$427K |
|
2217
Tarsus Pharmaceuticals
TARS
$2.08B
| $12.3M | ﹤0.01% |
609,736
+83,476
| +16% | +$1.69M |
|
2218
Apogee Therapeutics
APGE
$2.2B
| $12.3M | ﹤0.01% |
441,472
+40,236
| +10% | +$1.12M |
|
2219
BioLife Solutions
BLFS
$1.22B
| $12.3M | ﹤0.01% |
757,168
+35,722
| +5% | +$581K |
|
2220
Treace Medical Concepts
TMCI
$456M
| $12.3M | ﹤0.01% |
964,303
+50,720
| +6% | +$647K |
|
2221
Denny's
DENN
$264M
| $12.3M | ﹤0.01% |
1,128,459
-4,732
| -0.4% | -$51.5K |
|
2222
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $12.3M | ﹤0.01% |
699,613
+40,044
| +6% | +$702K |
|
2223
Castle Biosciences
CSTL
$621M
| $12.2M | ﹤0.01% |
566,115
+29,879
| +6% | +$645K |
|
|
ACRE
2224
Ares Commercial Real Estate
ACRE
$266M
| $12.2M | ﹤0.01% |
1,178,497
+56,519
| +5% | +$586K |
|
2225
Atlas Energy Solutions
AESI
$1.34B
| $12.2M | ﹤0.01% |
708,611
+376,682
| +113% | +$6.49M |
|